期刊文献+

中医防治方案对糖尿病肾病肾功能不全代偿期肾功能和血脂代谢的影响 被引量:9

下载PDF
导出
摘要 目的本研究旨在寻求能够改善糖尿病肾病肾功能不全的有效治疗方案。方法通过前瞻性、随机、安慰剂对照临床试验,观察中医辨证治疗方案(A组)、氯沙坦治疗方案(B组)和中医辨证结合氯沙坦治疗方案(C组),对161例糖尿病肾病肾功能不全代偿期患者肾功能和血脂代谢的影响。结果(1)三组治疗方案均能改善患者临床症状,A组和C组较B组疗效显著。(2)A组方案在降低肾功能指标方面优于B组,C组疗效居中。(3)A组在提高高密度脂蛋白-胆固醇、降低低密度脂蛋白-胆固醇方面有显著疗效;B组方案能有效降低血胆固醇,并在降低低密度脂蛋白-胆固醇方面优于C组方案。结论建立在现代医学降糖、降压基础治疗上的中医辨证论治方案能够较好地改善糖尿病肾病肾功能不全患者的临床症状、肾功能指标,并能提高高密度脂蛋白-胆固醇、降低低密度脂蛋白-胆固醇,改善血脂紊乱。
出处 《北京中医》 2007年第4期211-214,共4页 Beijing Journal of Traditional Chinese Medicine
基金 国家科技部"十五"攻关项目(2001BA701A13C)
  • 相关文献

参考文献12

  • 1Mogensen CE.Early Diabetic Renal Involvelent and Nephropathy.In:Alberti KGMM,Krall LP.The Diabetes Annual.Vol 3,Amsterdam,Elsevier Science publishers,1987:306.
  • 2王海燕 郑法雷 等.原发性肾小球疾病分型与治疗及诊断标准专题座谈会纪要[J].中华内科杂志,1993,2:131-134.
  • 3吕仁和,张洁荣,高彦彬.消渴病(糖尿病)中医分期辨证与疗效评定标准[J].中国医药学报,1993,8(3):54-56. 被引量:451
  • 4DCCT Research Group.The effect of intensive treatment of diabetes on the development and progression of long-term complication in IDDM.N Engl J Med,1993,329:977.
  • 5Juliana C.N.Chan,Nelson M.S.Wat,Wing-Yee So,et al.Renin Angiotensin Aldosterone System Blockade and Renal Disease in Patients With Type 2 Diabetes:An Asian perspective from the RENAAL study.Diabetes Care,2004,(27):874-879.
  • 6Lewis EJ,Hunsicker LG,Clarke WR,et al.Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.N Engl J Med,2001,345:851-860.
  • 7Lewis EJ,Hunsicker LG,Clarke WR,et al.Microaibuminuria Reduction with Valsartan in Patients with type2diabetes mellitus.Marval Study,2002,106:672-678.
  • 8Parving HH,Lehnert H,Brochner-Mortensen J,Gomis R,Andersen S,Arner P:The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.N Engl J Med,2001,345:870-878.
  • 9黎磊石,刘志红.糖尿病肾病的治疗[J].中华老年多器官疾病杂志,2002,1(3):171-173. 被引量:14
  • 10胡敏,王英.2型糖尿病肾病病人血脂代谢的分析[J].国际医药卫生导报,2005,11(18):34-36. 被引量:5

二级参考文献19

  • 1吕仁和,赵进喜,王越.糖尿病肾病临床研究述评[J].北京中医药大学学报,1994,17(2):2-6. 被引量:141
  • 2[1]The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993,329: 977-986.
  • 3[2]UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet, 1998,325: 837-853.
  • 4[3]Ruilope LM, Luno J. Angiotensin blockade in type 2 diabetic renal disease. Kidney Int Suppl, 2002,82:61-63.
  • 5[4]Pahor M, Psaty BM, Alderman MH, et al. Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. Diabetes Care, 2000,23:888-892.
  • 6[5]Fried LF, Qrchard TJ, Kasiske BL, et al. Effect of lipid reduction on the progression of renal diseases: a meta-analysis. Kidney Int, 2001,59:260-269.
  • 7[8]Brenner BM, Cooper ME, de Zeeuw D, et al. Effect of losartan on renal and cardiovascular outcome in patients with type 2 diabetes and nephropathy. N Engl J Med,2001,345: 861-869.
  • 8[9]Parving HH, Lehnert H, Brochner-Mortensen J, et al.The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med,2001,345: 870-878.
  • 9Keane WF. The role of lipids in renal disease: future challenges [J]. Kidney Int Suppl, 2000,57(75): 14S27~31
  • 10Bonnet F, Looper ME. Potential influence of lipid in diabetic nephropathy: insights from experimental data and clinical study [J]. Diabetic Metab, 2000,26(4):254 ~ 264

共引文献1215

同被引文献88

引证文献9

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部